SEC 13F Intelligence

Jensen Investment Management Inc / ABT

Jensen Investment Management Inc’s Abbott Laboratories Position

Does Jensen Investment Management Inc own Abbott Laboratories (ABT)? Yes1.49M shares worth $153M (+3.01% of its 13F portfolio) as of Q1 2026, down from 1.87M shares the prior filed quarter.

Position Value
$153M
Q1 2026
Shares
1.49M
% of Portfolio
+3.01%
Quarters Held
30
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $9MQ4 ’18Q1 ’19: $10MQ2 ’19: $10MQ3 ’19: $10MQ4 ’19: $10MQ4 ’19Q1 ’20: $9MQ2 ’20: $10MQ3 ’20: $12MQ4 ’20: $12MQ4 ’20Q1 ’21: $13MQ2 ’21: $12MQ3 ’21: $13MQ4 ’21: $15MQ4 ’21Q1 ’22: $13MQ2 ’22: $12MQ3 ’22: $10MQ4 ’22: $12MQ4 ’22Q1 ’23: $11MQ2 ’23: $11MQ3 ’23: $10MQ4 ’23: $11MQ4 ’23Q1 ’24: $12MQ2 ’24: $11MQ3 ’24: $12MQ4 ’24: $12MQ4 ’24Q1 ’25: $181MQ2 ’25: $324MQ3 ’25: $323MQ4 ’25: $235MQ4 ’25Q1 ’26: $153Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.49M$153M+3.01%
Q4 20251.87M$235M+3.69%
Q3 20252.41M$323M+4.00%
Q2 20252.38M$324M+3.79%
Q1 20251.37M$181M+2.00%
Q4 2024103.4K$12M+0.11%
Q3 2024103.4K$12M+0.10%
Q2 2024103.4K$11M+0.09%
Q1 2024103.4K$12M+0.09%
Q4 2023103.4K$11M+0.09%
Q3 2023103.4K$10M+0.08%
Q2 2023104.4K$11M+0.08%
Q1 2023106.2K$11M+0.08%
Q4 2022106.4K$12M+0.09%
Q3 2022106.4K$10M+0.09%
Q2 2022106.4K$12M+0.10%
Q1 2022107.0K$13M+0.09%
Q4 2021107.0K$15M+0.11%
Q3 2021107.5K$13M+0.10%
Q2 2021107.8K$12M+0.09%
Q1 2021108.2K$13M+0.10%
Q4 2020109.4K$12M+0.10%
Q3 2020109.3K$12M+0.11%
Q2 2020114.2K$10M+0.10%
Q1 2020114.2K$9M+0.10%
Q4 2019114.9K$10M+0.10%
Q3 2019114.9K$10M+0.10%
Q2 2019117.7K$10M+0.11%
Q1 2019118.9K$10M+0.11%
Q4 2018120.1K$9M+0.12%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Jensen Investment Management Inc’s full portfolio or all institutional holders of ABT.